Latest news
FDA Clears IND for RiboX’s RXIM002, Circular RNA CAR-T for ITP - The Clinical Trial VanguardThe Clinical Trial Vanguard · Sun, 09 Aug 2026 06:34:09 GMTScience Fiction Made Real: Kerry Rogers, MD, on How CAR T Works - AJMCAJMC · Sat, 08 Aug 2026 12:27:00 GMTWhat Makes an Optimal CAR T-Cell Therapy Candidate in Multiple Myeloma - CancerNetworkCancerNetwork · Fri, 07 Aug 2026 22:04:53 GMTFrom CAR T-Cell Therapy to ADCs: Tackling Oncology Access Gaps - AJMCAJMC · Fri, 07 Aug 2026 18:55:26 GMTWhy CAR T-Cell Therapy Should Precede Bispecifics in Multiple Myeloma - CancerNetworkCancerNetwork · Fri, 07 Aug 2026 15:09:51 GMTWhy Earlier CAR T-Cell Therapy May Benefit Patients With Multiple Myeloma - CancerNetworkCancerNetwork · Thu, 06 Aug 2026 22:09:47 GMTAdverse Event Management for Bispecific Antibodies and CAR T-Cell Therapies in Relapsed/Refractory Multiple Myeloma - Pharmacy TimesPharmacy Times · Thu, 06 Aug 2026 12:42:09 GMTIntracranial delivery of B7-H3-targeting CAR-T cells for recurrent glioblastoma: a phase 1 trial - NatureNature · Thu, 06 Aug 2026 09:06:55 GMT